Bernstein rotates its European SMID top picks portfolio, adding Convatec, Groupe SEB, CTS Eventim, GTT, TAG Immobilien, and X-FAB
AI summary card
Bernstein rotates its European SMID top picks portfolio, adding Convatec, Groupe SEB, CTS Eventim, GTT, TAG Immobilien, and X-FAB
The report makes major portfolio changes in a more demanding European small- and mid-cap environment, emphasizing valuation, earnings revisions, and clear catalysts rather than simply betting on the overall performance of the SMID asset class.
- Since the last rebalance in March, the equal-weight top picks portfolio delivered a total return of 12.2%, outperforming MSCI Europe Small by only 0.04 percentage points.
- The new additions cover themes including MedTech margin recovery, consumer self-help, live entertainment monetization, the LNG shipping cycle, Polish residential growth, and a recovery in specialty semiconductors.
- The report removes Exail Technologies, Davide Campari, Asmodee, Cirsa, Vallourec, and Havas, mainly due to narrowing upside, share prices anchored by acquisition offers, overhang from shareholder sell-downs, or capital reallocation.
- Although the SG strategy team downgraded its EMEA/Eurozone SMID asset class view to neutral, the report still believes relative valuation, healthy balance sheets, and higher expected EPS growth support a selective stock-picking strategy.
Report interpretation
Overview
This is an update report on a European mid-cap and SMID top picks portfolio. Bernstein conducted a quarterly rebalance of its Top Picks portfolio, replacing more than half of its constituents: adding Convatec, Groupe SEB, CTS Eventim, GTT, TAG Immobilien, and X-FAB, while removing Exail Technologies, Davide Campari, Asmodee, Cirsa, Vallourec, and Havas. The report acknowledges that the macro environment is less favorable for the SMID asset class than before, but argues that differentiated opportunities remain available through selective stocks with attractive valuations, earnings upgrade potential, and company-specific catalysts.
Core views
The core view is that European SMID is no longer suitable for a simple broad-based overweight, and investors should instead shift to bottom-up stock picking. Shared features of the new additions include remaining valuation recovery potential, identifiable catalysts over the next 6-18 months, possible earnings upgrades, or defensive growth and self-help improvement stories. The report also locks in profits on names that have already risen significantly or where upside has narrowed, while avoiding return constraints from acquisition offers, shareholder sell-downs, and sector rotation.
Analysis framework
The report uses a combination of equal-weight portfolio tracking, relative benchmark performance attribution, macro strategy judgment, and stock-specific fundamental catalysts. It first evaluates the top picks portfolio's performance versus MSCI Europe Small since March, then incorporates the SG strategy team's downgrade of the SMID asset class view, and finally updates the Top Picks list across dimensions such as valuation, earnings momentum, balance sheet strength, ESG, catalysts, and sector attractiveness.
Methodology notes
After each rebalance, the selected stocks are equally weighted, and performance is measured against benchmarks such as MSCI Europe Small.
This approach highlights stock selection contribution rather than market-cap weighting or single-sector exposure; the report shows that since the March rebalance, the portfolio delivered a total return of 12.2%, broadly in line with the small-cap benchmark.
Candidate stocks are compared across dimensions such as end-market attractiveness, pricing power, positive catalysts, self-help improvement, M&A-driven compound growth, balance sheet strength, and ESG.
The scorecard supports stock screening in a weakening macro environment, emphasizing identifiable catalysts and business quality.
Stock target prices may incorporate frameworks such as P/E multiples, DCF, WACC, and terminal growth.
For example, Convatec's target price is derived from an 80% weighting on P/E valuation and a 20% weighting on DCF valuation, with DCF assumptions of 8.5% WACC and 3.0% terminal growth.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Convatec (CTEC.LN)New Top Pick, Outperform, target price GBp275.00
- Strengths
- A chronic care MedTech transformation story with defensive end markets, where new product cycles and productivity improvements support revenue growth and margin expansion.
- Weaknesses
- Margin improvement in 2026 depends significantly on delivery in the second half.
- Comparison
- Compared with typical cyclical MedTech names, Convatec is more of a defensive growth and margin recovery story.
- Risks
- Inflation pressure, difficulty in bridging H2 margins, and uncertainty around CFO succession.
- Groupe SEB (SK.FP)New Top Pick, Outperform, target price €73.00
- Strengths
- The Rebound Plan is driving at least 5% organic sales growth, while cost savings and product innovation support margin recovery.
- Weaknesses
- After a difficult FY25 period, it still needs to prove the sustainability of the recovery.
- Comparison
- Compared with typical consumer goods companies, SEB's self-help improvement and social media/digital activation are key differentiators.
- Risks
- Weak consumer demand, execution falling short of expectations, and FX and cost volatility.
- CTS Eventim (EVD.GR)New Top Pick, Outperform, target price €94.00
- Strengths
- Resilient demand for live entertainment, with pricing power in premium events and the FanSale secondary ticketing platform driving high incremental margins.
- Weaknesses
- After the share price decline year-to-date, the market needs to re-recognize the quality of its earnings.
- Comparison
- Compared with traditional media, CTS benefits more directly from experiential consumption and ticketing digitalization.
- Risks
- Venue management, intensifying competition, and lower-than-expected M&A synergies.
- GTT (GTT.FP)New Top Pick, Outperform, target price €245.00
- Strengths
- Benefiting from a tight LNG shipping cycle, with high visibility on orders and backlog revenue, and potential upgrades to 2028-31 earnings expectations.
- Weaknesses
- Order timing remains uncertain, and the core valuation still relies mainly on the LNG containment business.
- Comparison
- The report rotates Vallourec exposure into GTT, viewing GTT as a better expression of the updated LNG theme.
- Risks
- LNG vessel order timing, energy cycle volatility, and less-than-expected upgrades to the long-term outlook.
- TAG Immobilien (TEG.GR)New Top Pick, Outperform, target price €18.30
- Strengths
- A combination of resilient German residential income and expansion of the Polish rental platform, with ROBYG re-IPO unlocking reinvestment capacity.
- Weaknesses
- Its FY26E NTA discount is narrower than peers, leaving a relatively limited valuation margin of safety.
- Comparison
- Compared with German residential peers, TAG's Polish growth runway is more differentiated.
- Risks
- Real estate financing conditions, execution of Polish projects, and changes in residential transactions and rental yields.
- X-FAB (XFAB.FP)New Top Pick, Outperform, target price €12.80
- Strengths
- The recovery in automotive semiconductors, open SiC platform, BCD-on-SOI, photonics, and microsystems represent multiple growth engines that are not yet fully utilized.
- Weaknesses
- Current earnings are affected by utilization rates and automotive inventory digestion.
- Comparison
- Valuation remains low versus wafer foundry peers, and rerating potential is substantial if 2028-30 earnings expectations are upgraded.
- Risks
- Delayed automotive recovery, negative operating leverage from fixed costs, and weaker-than-expected realization of specialty semiconductor demand.
Key data
- Portfolio performance12.2% total returnSince the 2026-03-23 rebalance, the equal-weight top picks portfolio has delivered a total return of 12.2%.
- Relative benchmark performance+0.04% relativeIt only slightly outperformed MSCI Europe Small on a total return basis.
- Number of additions6Convatec, Groupe SEB, CTS Eventim, TAG Immobilien, X-FAB.
- Number of removals6Exail Technologies, Davide Campari, Asmodee, Cirsa, Vallourec, Havas.
- Change in SMID asset viewEqual Weight / NeutralDue to weaker macro support, the SG strategy team downgraded its Eurozone small-cap versus large-cap view from Overweight to Neutral.
- Small-cap valuation13.2x forward P/E vs 14.9x large capsThe report cites the strategy view that small caps trade at about a 12% discount versus large caps.
- Expected EPS growth2026: 21%; 2027: 19%IBES consensus expects small-cap EPS growth above large caps at 17% and 13%.
- X-FAB upside80%The table shows XFAB.FP at a current price of €7.12 and a target price of €12.80.
- CTS Eventim upside66%The table shows EVD.GR at a current price of €56.60 and a target price of €94.00.
- Groupe SEB upside46%The table shows SK.FP at a current price of €49.94 and a target price of €73.00.
Impact & implications
The implication for investors is that, against a backdrop of weakening macro tailwinds for European small and mid caps, they should reduce reliance on overall SMID beta and shift toward stocks driven by earnings recovery, self-help improvement, structural growth, and clear event catalysts. The new additions provide diversified thematic exposure, but also mean returns will depend more on company execution, industry cycle delivery, and valuation rerating.
Risks
- The macro environment no longer supports sustained outperformance of SMID versus large caps, with weaker M1 liquidity and manufacturing PMI indicators.
- Downgrades to Eurozone GDP expectations and declining overall risk appetite for European equities may pressure valuations.
- The investment case for the new additions depends heavily on company execution, cost savings, order delivery, and earnings upgrades.
- Acquisition offers, shareholder sell-downs, sector rotation, or commodity cycles may limit upside in some names.
- Small-cap liquidity and style rotation risks may amplify short-term volatility.
What to watch
- Whether Convatec's margins improve meaningfully in the second half as guided, and whether 2027 inflation pressure can be offset by productivity measures.
- The pace of consensus upgrades to GTT's 2028-31 earnings expectations, and the timing of LNG vessel order awards.
- CTS Eventim's FanSale expansion, premium ticketing pricing power, and realization of M&A synergies.
- Execution of Groupe SEB's Rebound Plan, the €200m cost-saving target, and the path of operating margin recovery.
- TAG Immobilien's execution in German M&A, expansion of the Polish rental platform, and redeployment of ROBYG capital.
- Recovery in X-FAB's automotive demand, conversion of SiC/BCD-on-SOI orders, and utilization rate improvement.
- Macro indicators for SMID relative to large caps, including liquidity, the PMI new orders-to-inventory ratio, the rate path, and EPS expectation differentials.